![Wei Fu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 89 M $ al 31/05/2026
El Sr. Wei Fu es director independiente de I-Mab, presidente de Everest Medicines Ltd., director general de Shanghai Kangshiqiao Business Consulting Co. Ltd., Consejero Delegado y Socio Director de C-Bridge Capital Investment Management Ltd. y Consejero Delegado de Cbc Group Co. Ltd. Ltd. Es miembro del Consejo de Administración de I-Mab, Ascletis Biopharmaceutical (Hangzhou) Co. Ltd., Everest Medicines (Singapore) Pte Ltd., Everest Medicines II BVI Ltd., Everest Medicines II HK Ltd., Everest Medicines II Ltd., Everonc Medicines Ltd. y Everonc Medicines, Inc. Anteriormente, el Sr. Fu fue director general del departamento de inversiones de Far East Horizon Ltd., director de Pekín de Themes Investment Management Ltd., director asociado del departamento de capital privado de Standard Chartered Business Consulting Beijing Co. Ltd., y director no ejecutivo de Ascletis Pharma, Inc. Se licenció en la Universidad Tecnológica de Nanyang.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EVEREST MEDICINES LTD. 6,13 % | 16/06/2026 | 21.683.167 ( 6,13 % ) | 83 M $ | 31/05/2026 |
NOVABRIDGE BIOSCIENCES 3,76 % | 29/06/2026 | 7.129.885 ( 3,76 % ) | 6 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Presidente | 15/07/2024 |
| EVEREST MEDICINES LIMITED | Director/Miembro de la Junta | 09/10/2025 |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Director Ejecutivo | 01/01/2014 |
Everest Medicines (Singapore) Pte Ltd. | Director/Miembro de la Junta | - |
C-Bridge Capital GP IV Ltd.
 C-Bridge Capital GP IV Ltd. Financial ConglomeratesFinance Provides investment services | Director/Miembro de la Junta | - |
AffaMed Therapeutics
 AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutics for ophthalmology patients | Presidente | - |
Affamed Therapeutics (Us), Inc.
 Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Director/Miembro de la Junta | - |
Everest Medicines II BVI Ltd. | Director/Miembro de la Junta | - |
Everest Medicines II HK Ltd. | Director/Miembro de la Junta | - |
| ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 21 |
|---|---|
Nanyang Technological University
 Nanyang Technological University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Themes Investment Management Ltd.
 Themes Investment Management Ltd. Investment ManagersFinance Themes Investment Management invests in companies located in China. It provides financing for buyout and special situation transactions. It also makes co-investment. | Finance |
Far East Horizon Ltd.
 Far East Horizon Ltd. Finance/Rental/LeasingFinance Provides financial and advisory & industrial operation services | Finance |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Manufactures therapeutic products | Health Technology |
Hugel, Inc.
 Hugel, Inc. BiotechnologyHealth Technology Manufactures and supplies toxin products, cosmetics, medical devices and pharmaceuticals | Health Technology |
CBC Group (Singapore) Pte. Ltd.
CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Finance |
Everest Medicines Ltd.
 Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs | Health Technology |
Ascletis Pharma, Inc.
 Ascletis Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology firm which develops drugs for HIV, HCV and HBV diseases | Health Technology |
CBC Group Co., Ltd. | |
AffaMed Therapeutics
AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutics for ophthalmology patients | Health Technology |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
C-Bridge Capital Investment Management Ltd. | |
Standard Chartered Business Consulting Beijing Co. Ltd. | |
Everest Medicines II Ltd.
 Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Everest Medicines II HK Ltd. | |
Everest Medicines (Singapore) Pte Ltd. | |
Everonc Medicines Ltd. | |
Everonc Medicines, Inc. | |
Everest Medicines II BVI Ltd. | |
Affamed Therapeutics (Us), Inc.
Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
C-Bridge Capital GP IV Ltd.
C-Bridge Capital GP IV Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
